Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04687358
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2020-12-17
Brief Title:
REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
Sponsor:
Kiniksa Pharmaceuticals UK Ltd
Organization:
Kiniksa Pharmaceuticals GmbH
Study Overview
Official Title:
Registry of the Natural History of Recurrent Pericarditis in Pediatric and Adult Patients
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RESONANCE
Brief Summary:
The registry will focus on furthering the understanding of the natural history of recurrent pericarditis RP as well as document RP-related clinical health-related quality of life HRQoL and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None